Eversens

eversens.com ↗ ·Pamplona ·Seed

Eversens is a Spanish medtech company that designs, develops, manufactures, and commercializes non-invasive breath-analysis devices for detecting exhaled biomarkers, used to diagnose and monitor respiratory diseases like asthma. Its flagship product, evernoa BASE, measures fractional exhaled nitric oxide (FeNO), a biomarker for airway inflammation. Founded in 2015 as a spin-off of the Public University of Navarra (UPNA), it is ISO 13485:2018 certified and based in Pamplona.

Founded
2015
Founders
4
Total funds raised
€1.6M
Rounds
4
Investors
5
Last round
Jan 2024
SectorsMedtech, Diagnostics, Respiratory health, Biosensors Start-up MapHealthtech & Bio › Diagnostics & precision medicine testing

Suggest a correction

Founders

Francisco J. Arregui
Co-Founder
Ignacio R. Matías
Co-Founder
Juan Mari Pérez Azpeitia
Co-Founder & CTO
Leyre Ruete Ibarrola
CEO & Founding Partner

Global models 3

Owlstone Medical
United Kingdom · www.owlstonemedical.com ↗
Owlstone Medical develops and sells breath-analysis devices that detect exhaled biomarkers to diagnose and monitor disease, including respiratory conditions, which is the same device model as Eversens.
$170M+Comparable
Aerocrine
Aerocrine was the VC-backed company that created the NIOX FeNO device for measuring airway inflammation in asthma, making it the most direct precedent for Eversens's evernoa.
$150M+Comparable
Breathonix
Breathonix is a university spin-off that builds and sells breath-analysis diagnostic devices based on exhaled biomarkers, which is the same model as Eversens.
$10MComparable

In the same niche 48 others

See all in the Start-ups Map →

Notes: Most funded first

Investors 5

Open as list →

Funding rounds 4

·1 not counted
DateRoundAmountLead
Not counted (1)

Not counted in totals

Start typing to search across everything.
↑↓ navigate↵ openesc close? shortcuts
Keyboard shortcuts
/ Ctrl K
Search
j k
Next or previous row
↵
Open the row
Ctrl ↵
Open it in a new tab
[ ]
Previous or next page
?
This list